Intercept Pharmaceuticals
Manufacturing · New York, United States · 500 Employees
Who is Intercept Pharmaceuticals
Intercept is a biotech firm focused on the development of products to treat liver diseases. Intercept was founded in 2002 and is headquartered in New York, NY.Read More
Headquarters:
10 Hudson Yards, Fl 37, New York City, New York, 10001, United States
Phone Number:
(646) 747-1000
Revenue:
$354 Million
Stock Symbol:
ICPT
Intercept Pharmaceuticals's Social Media
Popular Searches:
intercept pharmaceuticals inc
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals , Inc.
Intercept Pharmaceuticals
Intercept Pharmaceuticals Inc.
Top Competitors of Intercept Pharmaceuticals
Intercept Pharmaceuticals's Org Chart
Phone
Email
Intercept Pharmaceuticals Company Metrics
Funding
| Funding Date | Round | Amount | Investors | |
|---|---|---|---|---|
May 10, 2019 | Stock Issuance/Offering | $200M | - | |
May 10, 2019 | Debt | $210M | - | |
Apr 05, 2018 | Stock Issuance/Offering | $250M | Samsara BioCapital, L.P. | + 1 more  |
See More
$1B
Total Funding Amount
$200M
Most Recent Funding Amount
11
Number of Funding Rounds
Revenue
| Quarter | Revenue |
|---|---|
'21 - Q1 | 261080000 |
'21 - Q2 | 261080000 |
Acquisitions & Subsidiaries
Dec 14, 2018
ADVANZ PHARMA
Oct 31, 2017
Abcur
Nov 25, 2014
Correvio
Mar 30, 2014
Paralex
Nov 21, 2009
Pinnacle Biologics
Artesian Therapeutics
See More Acquisitions & Subsidiaries
Intercept Pharmaceuticals's Tech Stack
Intercept Pharmaceuticals News & Media
Intercept Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Worldwide Ocaliva® non-GAAP adjusted net sales in PBC of $100.4 million; U.S. net sales of $71.8 million representing 5% growth over the prior year quarter
Aug 3, 2022
Intercept Announces PBC Data Presentations at The International Liver Congress™ 2022
MORRISTOWN, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that multiple abstracts highlighting the benefits of obeticholic acid (OCA) in individuals with primary biliary cholangitis (PBC) will be presented at the International Liver Congress™ 2022, the 57th Annual Meeting of the European AssociatJun 21, 2022
Intercept Provides Update on NASH Regulatory Timeline
MORRISTOWN, N.J., June 06, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral liver diseases, today announced an update on the timing of its pre-submission meeting with the U.S. Food and Drug Administration (FDA) regarding the potential resubmission of its nonalcoholic steatohepatitis (NASH) New Drug Application (NDA) based on an interim analysis of the REGENJun 6, 2022Subscribe to "Intercept Pharmaceuticals" News
Frequently Asked Questions regarding Intercept Pharmaceuticals
Where are Intercept Pharmaceuticals’s headquarters?
Intercept Pharmaceuticals’s headquarters are in 10 Hudson Yards, Fl 37, New York City, New York, 10001, United States
What is Intercept Pharmaceuticals’s phone number?
Intercept Pharmaceuticals’s phone number is (646) 747-1000
What is Intercept Pharmaceuticals’s stock symbol?
Intercept Pharmaceuticals’s stock symbol is ICPT
What is Intercept Pharmaceuticals’s official website?
Intercept Pharmaceuticals’s official website is www.interceptpharma.com
What is Intercept Pharmaceuticals’s Revenue?
Intercept Pharmaceuticals’s revenue is $354 Million
What is Intercept Pharmaceuticals’s SIC code?
Intercept Pharmaceuticals’s SIC: 28,283
What is Intercept Pharmaceuticals’s NAICS code?
Intercept Pharmaceuticals’s NAICS: 325414,32541
How many employees are working in Intercept Pharmaceuticals?
Intercept Pharmaceuticals has 500 employees
What is Intercept Pharmaceuticals’s industry?
Intercept Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Chemicals & Related Products
Who are Intercept Pharmaceuticals’s main competitors?
Intercept Pharmaceuticals's main competitors are: Acceleron Pharma, Atara Bio, Relypsa, GBT
What companies has Intercept Pharmaceuticals acquired?
Intercept Pharmaceuticals has acquired the companies: ADVANZ PHARMA, Abcur, Correvio, Paralex
What is Intercept Pharmaceuticals's tech stack?
The technologies that are used by Intercept Pharmaceuticals are: Microsoft Azure, Achievers, ASP.NET, SonicWALL
Who is Intercept Pharmaceuticals's CEO?
Intercept Pharmaceuticals's CEO is Jerome Durso
Who is Intercept Pharmaceuticals's CFO?
Intercept Pharmaceuticals's CFO is Andrew Saik
Slide to rate Alex Martin as a Chief Executive Officer
4.4/5 on G2 Crowd
Test Drive ZoomInfo's Directories
Browse Directories
